PMID- 30335505 OWN - NLM STAT- MEDLINE DCOM- 20200728 LR - 20200728 IS - 2047-4881 (Electronic) IS - 2047-4873 (Linking) VI - 26 IP - 1 DP - 2019 Jan TI - Long-term mortality is increased in patients with undetected prediabetes and type-2 diabetes hospitalized for worsening heart failure and reduced ejection fraction. PG - 72-82 LID - 10.1177/2047487318807767 [doi] AB - BACKGROUND: We assessed the prevalence of newly diagnosed prediabetes and type-2 diabetes mellitus (T2DM), and their impact on long-term mortality in patients hospitalized for worsening heart failure with reduced ejection fraction (HFrEF). METHODS: We included patients hospitalized with HFrEF and New York Heart Association (NYHA) functional class II-III. Baseline two-hour oral glucose tolerance test was used to classify patients as normoglycaemic or having newly diagnosed prediabetes or T2DM. Outcomes included post-discharge all-cause and cardiovascular mortality during the median follow-up of 2.1 years. RESULTS: At baseline, out of 150 patients (mean-age 57 +/- 12 years; 88% male), prediabetes was diagnosed in 65 (43%) patients, and T2DM in 29 (19%) patients. These patients were older and more often with NYHA class III symptoms, but distribution of comorbidities was similar to normoglycaemic patients. Taking normoglycaemic patients as a reference, adjusted risk of all-cause mortality was significantly increased both in patients with prediabetes (hazard ratio, 2.6; 95% confidence interval (CI), 1.1-6.3; p = 0.040) and in patients with T2DM (hazard ratio, 5.3; 95% CI, 1.7-15.3; p = 0.023). Likewise, both prediabetes (hazard ratio, 2.9; 95% CI, 1.1-7.9; p = 0.041) and T2DM (hazard ratio, 9.7; 95% CI 2.9-36.7; p = 0.018) independently increased the risk of cardiovascular mortality compared with normoglycaemic individuals. There was no interaction between either prediabetes or T2DM and heart failure aetiology or gender on study outcomes (all interaction p-values > 0.05). CONCLUSIONS: Newly diagnosed prediabetes and T2DM are highly prevalent in patients hospitalized for worsening HFrEF and NYHA functional class II-III. Importantly, they impose independently increased long-term risk of higher all-cause and cardiovascular mortality. FAU - Pavlovic, Andrija AU - Pavlovic A AD - 1 Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia. FAU - Polovina, Marija AU - Polovina M AD - 1 Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia. AD - 2 University of Belgrade, Faculty of Medicine, Serbia. FAU - Ristic, Arsen AU - Ristic A AD - 1 Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia. AD - 2 University of Belgrade, Faculty of Medicine, Serbia. FAU - Seferovic, Jelena P AU - Seferovic JP AD - 2 University of Belgrade, Faculty of Medicine, Serbia. AD - 3 Clinic of Endocrinology and Metabolic Disorders, Clinical Centre of Serbia, Belgrade, Serbia. FAU - Veljic, Ivana AU - Veljic I AD - 1 Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia. FAU - Simeunovic, Dejan AU - Simeunovic D AD - 1 Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia. AD - 2 University of Belgrade, Faculty of Medicine, Serbia. FAU - Milinkovic, Ivan AU - Milinkovic I AD - 1 Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia. FAU - Krljanac, Gordana AU - Krljanac G AD - 1 Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia. AD - 2 University of Belgrade, Faculty of Medicine, Serbia. FAU - Asanin, Milika AU - Asanin M AD - 1 Department of Cardiology, Clinical Centre of Serbia, Belgrade, Serbia. AD - 2 University of Belgrade, Faculty of Medicine, Serbia. FAU - Ostric-Pavlovic, Irena AU - Ostric-Pavlovic I AD - 4 Department of Allergology and Clinical Immunology, Belgrade, Serbia. FAU - Seferovic, Petar M AU - Seferovic PM AD - 2 University of Belgrade, Faculty of Medicine, Serbia. LA - eng PT - Journal Article PT - Observational Study DEP - 20181018 PL - England TA - Eur J Prev Cardiol JT - European journal of preventive cardiology JID - 101564430 SB - IM CIN - Eur J Prev Cardiol. 2019 Jan;26(1):68-71. PMID: 30370791 MH - Adult MH - Aged MH - Diabetes Mellitus, Type 2/diagnosis/*mortality MH - Disease Progression MH - Female MH - Heart Failure/diagnosis/*mortality/physiopathology/therapy MH - *Hospitalization MH - Humans MH - Male MH - Middle Aged MH - Prediabetic State/diagnosis/*mortality MH - Prevalence MH - Prognosis MH - Prospective Studies MH - Risk Assessment MH - Risk Factors MH - Serbia/epidemiology MH - *Stroke Volume MH - Time Factors MH - *Ventricular Function, Left OTO - NOTNLM OT - Heart failure with reduced ejection fraction OT - all-cause mortality OT - cardiovascular mortality OT - diabetes OT - prediabetes EDAT- 2018/10/20 06:00 MHDA- 2020/07/29 06:00 CRDT- 2018/10/19 06:00 PHST- 2018/10/20 06:00 [pubmed] PHST- 2020/07/29 06:00 [medline] PHST- 2018/10/19 06:00 [entrez] AID - 10.1177/2047487318807767 [doi] PST - ppublish SO - Eur J Prev Cardiol. 2019 Jan;26(1):72-82. doi: 10.1177/2047487318807767. Epub 2018 Oct 18.